This paper explores the dual focus of developing effective drug formularies and fostering biotechnology growth to revolutionize healthcare systems in emerging economies. When strategically designed, drug formularies can enhance affordability, accessibility, and quality of essential medicines, while integrating traditional medicine where relevant. Concurrently, biotechnology serves as a transformative force, offering innovative solutions in diagnostics, therapeutics, and vaccine production. The paper emphasizes the importance of building robust regulatory frameworks, strengthening research ecosystems, and fostering public-private collaborations to drive progress. It also highlights the role of education, workforce development, and supportive intellectual property policies in creating a sustainable healthcare infrastructure. By addressing these interconnected dimensions, the paper proposes actionable strategies for governments, industry players, and academia to collaboratively advance healthcare innovation, improve public health outcomes, and contribute to the economic growth of emerging economies.